Pharmaceutical & Drug Policy
Marta Wosińska’s testimony before the Senate Special Committee on Aging
Pharmaceutical & Drug Policy
Rethinking manufacturing quality oversight for prescription drugs
Pharmaceutical & Drug Policy
FDA’s new Commissioner’s National Priority Voucher has lofty goals. Can it deliver?
Pharmaceutical & Drug Policy
Amicus brief in support of HHS appeal regarding the IRA’s drug pricing provisions
Experts
Vanda Felbab-Brown
Director
- Initiative on Nonstate Armed Actors,
Co-Director
- Africa Security Initiative,
Senior Fellow
- Foreign Policy, Strobe Talbott Center for Security, Strategy, and Technology
Ryan Conrad
Visiting Fellow
- Economic Studies, Center on Health Policy